Mesothelioma Trials: Eloxatin® and Gemcitabine

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

Columbia University in New York City is seeking participants in a clinical trial study of the drugs Oxaliplatin (Eloxatin®) and Gemcitabine to treat malignant mesothelioma. In this Phase II study, patients will be given the two drugs in combination in order to determine the tumor response rate.

At this time, the study is only being conducted at Columbia University Medical Center in New York City. For more information about this clinical trial, contact Lilian Batista or Evelyn Reyes.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.